Mavyret on AARP Medicare Rx Preferred from UHC (S5921-396)
glecaprevir and pibrentasvir
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 140 per 28 days.
$4,393.26
Patient pays / month, after deductible
$4,482.96
Patient pays / month, before the $130.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
MAVYRET 20/50 mg Pellet at a preferred retail pharmacy, from the plan's negotiated price of $14,171.81 for a month. Other covered strengths are listed below.
Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| MAVYRET 20/50 mg Pellet | 5 | $4,393.26 | PA · 140 per 28 days |
| MAVYRET 40/100 mg Tablet, Film Coated | 5 | $4,448.13 | PA · 84 per 28 days |
Other Hepatitis C drugs on this plan
Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5921-396